Steven Cohen’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
Steven Cohen's KYMR Position: Q3 2026 in Review
Steven Cohen opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 211,218 shares worth $23.6M. The stake represents 0.03% of the portfolio and ranks #817 among its holdings. This is a return to the name: Steven Cohen previously reported a position in KYMR as recently as Q4 2025.
Steven Cohen first reported a position in KYMR in Q2 2021 and has held it in 9 quarters since. The position peaked at $27.6M in Q1 2022. 298 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- Steven Cohen held 211,218 shares of Kymera Therapeutics worth $23.6M as of Q3 2026.
- Kymera Therapeutics was a new Steven Cohen position in Q3 2026.
- Kymera Therapeutics made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #817 holding.
- Steven Cohen first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 9 quarters since.
- Steven Cohen's Kymera Therapeutics position peaked at $27.6M in Q1 2022.
- 298 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.